T. Rowe Price reports 6.8% stake in United States Antimony
T. Rowe Price Associates, Inc. reported beneficial ownership of common stock of United States Antimony Corp. As of June 30, 2026, it reported beneficial ownership of 10,031,734 shares of common stock, representing 6.8% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. reported beneficial ownership of common stock of United States Antimony Corp. As of June 30, 2026, it reported beneficial ownership of 10,031,734 shares of common stock, representing 6.8% of the class.
The firm reported sole voting powersole dispositive power
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
Sole Voting Power financial
dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What dispositive power does T. Rowe Price Associates report for its UAMY position?
Who signed the Schedule 13G filing for UAMY on behalf of T. Rowe Price Associates?
AI-generated analysis. How Rhea-AI works. Not financial advice.